Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1933 1
1944 1
1947 3
1948 1
1951 2
1952 2
1953 3
1954 3
1955 8
1956 3
1957 9
1958 7
1959 8
1960 4
1961 7
1962 7
1963 19
1964 9
1965 7
1966 7
1967 7
1968 17
1969 17
1970 14
1971 17
1972 17
1973 21
1974 18
1975 18
1976 16
1977 21
1978 27
1979 23
1980 19
1981 27
1982 19
1983 18
1984 27
1985 15
1986 18
1987 20
1988 32
1989 32
1990 33
1991 28
1992 36
1993 40
1994 38
1995 32
1996 36
1997 38
1998 51
1999 46
2000 42
2001 34
2002 42
2003 32
2004 48
2005 54
2006 53
2007 57
2008 54
2009 72
2010 61
2011 66
2012 72
2013 68
2014 75
2015 74
2016 75
2017 65
2018 75
2019 77
2020 75
2021 76
2022 59
2023 69
2024 59
2025 59
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,357 results

Results by year

Filters applied: . Clear all
Page 1
A no-brainer.
Butler RM, Gray WA. Butler RM, et al. Catheter Cardiovasc Interv. 2020 Nov;96(6):1304-1305. doi: 10.1002/ccd.29360. Catheter Cardiovasc Interv. 2020. PMID: 33217187
Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation.
Bosma KJ, Burns KEA, Martin CM, Skrobik Y, Mancebo Cortés J, Mulligan S, Lafreniere-Roula M, Thorpe KE, Suárez Montero JC, Morán Chorro I, Rodríguez-Farré N, Butler R, Bentall T, Beduneau G, Enguerrand P, Santos M, Piraino T, Spadaro S, Montanaro F, Basmaji J, Campbell E, Mercat A, Beloncle FM, Carteaux G, Maraffi T, Charbonney E, Lecronier M, Dres M, Arabi YM, Amaral ACK, Marinoff N, Adhikari NKJ, Geagea A, Shin P, Vaporidi K, Kondili E, Shahin J, Campisi J, Rodriguez PO, Setten M, Goligher EC, Ferguson ND, Fanelli V, Ferreyra G, Lellouche F, Sibley S, Brochard L; PROMIZING Study Investigators, the Canadian Critical Care Trials Group, and the REVA Network. Bosma KJ, et al. Among authors: butler r. N Engl J Med. 2025 Sep 18;393(11):1088-1103. doi: 10.1056/NEJMoa2505708. Epub 2025 Jun 13. N Engl J Med. 2025. PMID: 40513024 Clinical Trial.
Reply by Authors.
Frainey BT, Majerus SJA, Derisavifard S, Lewis KC, Williams AR, Balog BM, Butler RS, Goldman HB, Damaser MS. Frainey BT, et al. Among authors: butler rs. J Urol. 2023 Jul;210(1):195. doi: 10.1097/JU.0000000000003451.02. Epub 2023 Jun 9. J Urol. 2023. PMID: 37293724 No abstract available.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.
Jones RH, Casbard A, Carucci M, Cox C, Butler R, Alchami F, Madden TA, Bale C, Bezecny P, Joffe J, Moon S, Twelves C, Venkitaraman R, Waters S, Foxley A, Howell SJ. Jones RH, et al. Among authors: butler r. Lancet Oncol. 2020 Mar;21(3):345-357. doi: 10.1016/S1470-2045(19)30817-4. Epub 2020 Feb 5. Lancet Oncol. 2020. PMID: 32035020 Free PMC article. Clinical Trial.
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction.
England E, Rees DG, Scott IC, Carmen S, Chan DTY, Chaillan Huntington CE, Houslay KF, Erngren T, Penney M, Majithiya JB, Rapley L, Sims DA, Hollins C, Hinchy EC, Strain MD, Kemp BP, Corkill DJ, May RD, Vousden KA, Butler RJ, Mustelin T, Vaughan TJ, Lowe DC, Colley C, Cohen ES. England E, et al. Among authors: butler rj. Sci Rep. 2023 Jun 17;13(1):9825. doi: 10.1038/s41598-023-36642-y. Sci Rep. 2023. PMID: 37330528 Free PMC article.
Thixotropic world.
Butler R. Butler R. Nature. 2024 Nov 13. doi: 10.1038/d41586-024-03685-8. Online ahead of print. Nature. 2024. PMID: 39537811 No abstract available.
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.
Howell SJ, Casbard A, Carucci M, Ingarfield K, Butler R, Morgan S, Meissner M, Bale C, Bezecny P, Moon S, Twelves C, Venkitaraman R, Waters S, de Bruin EC, Schiavon G, Foxley A, Jones RH. Howell SJ, et al. Among authors: butler r. Lancet Oncol. 2022 Jul;23(7):851-864. doi: 10.1016/S1470-2045(22)00284-4. Epub 2022 Jun 4. Lancet Oncol. 2022. PMID: 35671774 Free PMC article. Clinical Trial.
2,357 results